Infectious Diseases Point-Of-Care (POC) Diagnostic Market Size, Share | Industry Trends 2023

The global infectious diseases point-of-care (poc) diagnostic market size was valued at USD 2,547.8 million in 2021 and is expected to grow at a CAGR of 7.2% during the forecast period 2022 to 2028. Point-of-care (POC) testing, also known as bedside testing, refers to diagnostic tests performed outside of a laboratory setting, as close to the patient as possible. With advancements in medical technology, a wide range of health factors can now be quickly and easily assessed, making screening, evaluation, diagnosis, therapy, and prognoses more efficient. Compared to traditional laboratory testing, which involves multiple phases, including analytical, pre-analytical, and post-analytical phases, POC testing eliminates most of these steps, reducing the risk of errors. Over the past decade, there has been a significant increase in demand for POC testing due to the need for reliable and timely testing both inside and outside of hospitals. The availability of portable, handheld, and transportable devices has contributed to the shift towards POC testing in various medical settings, including homes, workplaces, emergency care centers, and convenient clinics.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/infectious-diseases-point-of-care-poc-diagnostic-market/

Infectious diseases Point-of-Care (POC) Diagnostic Market Growth Factors:
The infectious diseases Point-of-Care (POC) diagnostic market is expected to experience significant growth in the coming years. One of the major factors driving this growth is the increasing prevalence of infectious diseases worldwide, coupled with the need for rapid and accurate diagnosis to ensure appropriate treatment and prevent the spread of infections.

The development of new and innovative POC diagnostic technologies is also expected to drive market growth. These technologies are becoming more sophisticated, with improved accuracy and reliability, as well as faster turnaround times. Additionally, the availability of affordable and user-friendly POC diagnostic devices is expected to increase demand for these products, particularly in resource-limited settings.

Moreover, the COVID-19 pandemic has further accelerated the demand for POC diagnostic testing, as it is critical for rapid identification and management of infected individuals. As a result, many companies have focused on developing and commercializing POC diagnostic tests for COVID-19, which is expected to drive market growth in the short term.

Overall, the infectious diseases POC diagnostic market is expected to experience sustained growth in the coming years, driven by increasing demand for rapid and accurate diagnostic testing, technological advancements, and the need for effective management of infectious diseases.

Infectious Diseases Point-Of-Care (POC) Diagnostic Market Segmentation:
1) By Component Type: Instruments, Reagents and Kits, Software and Services
2) By Technology: Lateral Flow Immunoassay, Agglutination Test, Molecular Diagnostics, others
3) By Disease: HIV, Hospital Acquired Infections, HBV, Respiratory Tract Infections, HPV, HCV, Tuberculosis, COVID-19, Others
4) By End User: Home Care, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes, Others.

Request Sample: https://precisionbusinessinsights.com/request-sample?product_id=54790

Infectious diseases Point-of-Care (POC) Diagnostic Market Regional Analysis:
The Point-of-Care (PoC) infectious disease testing market is currently dominated by North America, mainly due to the presence of established healthcare systems and large companies. The US contributes the highest revenue share due to the adoption of advanced technologies in the region. In contrast, the Asia Pacific (APAC) region is expected to have the fastest growth rate due to increased research and development investments in patient-centric institutions in countries like Japan and China. APAC's growth will be further supported by the rising burden of chronic infectious diseases and government initiatives aimed at promoting early detection. To take advantage of this growth opportunity, businesses in APAC are focusing on developing innovative assays.

The global infectious diseases point-of-care (poc) diagnostic market key players are Cepheid Inc. (Danaher Corporation) (U.S.), Abbott Laboratories, Inc. (U.S.), Hoffmann La Roche Limited (Switzerland), Beckman Coulter, Inc. (U.S.), Siemens AG (Germany), Johnson & Johnson Services, Inc. (U.S.), Instrumentation Laboratory (U.S.), Becton, Dickinson and Company (U.S.)

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.